Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:36831393

A Novel Blood Proteomic Signature for Prostate Cancer.

Ammara Muazzam · Matt Spick · Olivier N F Cexus · Bethany Geary · Fowz Azhar · Hardev Pandha · Agnieszka Michael · Rachel Reed · Sarah Lennon · Lee A Gethings · Robert S Plumb · Anthony D Whetton · Nophar Geifman · Paul A Townsend

Cancers · 2023 doi:10.3390/cancers15041051

Paper

complete

Experiment

partial

Data

partial

Analysis

partial

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:36831393
kind
science-record
content_hash
sha256:3c91e24ed2c7c79a658ea86f15d528cce702f6da4ef64371694b00bf75034994
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T19:01:26Z
updated_at
2026-11-01T22:51:21Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
A Novel Blood Proteomic Signature for Prostate Cancer.
doi
10.3390/cancers15041051
pmid
36831393
authors array · 14 items
[0]
Ammara Muazzam
[1]
Matt Spick
[2]
Olivier N F Cexus
[3]
Bethany Geary
[4]
Fowz Azhar
[5]
Hardev Pandha
[6]
Agnieszka Michael
[7]
Rachel Reed
[8]
Sarah Lennon
[9]
Lee A Gethings
[10]
Robert S Plumb
[11]
Anthony D Whetton
[12]
Nophar Geifman
[13]
Paul A Townsend
journal
Cancers
year
2023
abstract
Prostate cancer is the most common malignant tumour in men. Improved testing for diagnosis, risk prediction, and response to treatment would improve care. Here, we identified a proteomic signature of prostate cancer in peripheral blood using data-independent acquisition mass spectrometry combined with machine learning. A highly predictive signature was derived, which was associated with relevant pathways, including the coagulation, complement, and clotting cascades, as well as plasma lipoprotein particle remodeling. We further validated the identified biomarkers against a second cohort, identifying a panel of five key markers (GP5, SERPINA5, ECM1, IGHG1, and THBS1) which retained most of the diagnostic power of the overall dataset, achieving an AUC of 0.91. Taken together, this study provides a proteomic signature complementary to PSA for the diagnosis of patients with localised prostate cancer, with the further potential for assessing risk of future development of prostate cancer. Data are available via ProteomeXchange with identifier PXD025484.
claims array · 3 items
[0] object · 6 fields
id
claim-method
statement
A random forest (RF) model was used for feature selection from the initial protein dataset, splitting the data in the ratio of 67:33 (training/testing using stratification), setting ntree to 1000, maximum leaf nodes to 16, and random seed to 1. Recursive feature elimination with cross-validation was used to select the individual features from the training set (maximising accuracy). Classifier model construction was performed using logistic regression.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:36831393
locator
sections[9] "2.7. Biomarker Analysis and Development and Evaluation of Classification and Regression Models" paragraph 2
quote
A random forest (RF) model was used for feature selection from the initial protein dataset, splitting the data in the ratio of 67:33 (training/testing using stratification), setting ntree to 1000, maximum leaf nodes to 16, and random seed to 1. Recursive feature elimination with cross-validation was used to select the individual features from the training set (maximising accuracy). Classifier model construction was performed using logistic regression.
state
complete
[1] object · 6 fields
id
claim-data-access
statement
All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary information. Raw data files are available via ProteomeXchange with identifier PXD025484 and can be accessed through ProteomeXchange using reviewer account details: Username: reviewer_pxd025484@ebi.ac.uk and Password: W0lWREBN.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:36831393
locator
sections[22] "Data Availability Statement" paragraph 2
quote
All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary information. Raw data files are available via ProteomeXchange with identifier PXD025484 and can be accessed through ProteomeXchange using reviewer account details: Username: reviewer_pxd025484@ebi.ac.uk and Password: W0lWREBN.
state
complete
[2] object · 6 fields
id
claim-target-result
statement
A five-marker serum protein signature—GP5, SERPINA5, ECM1, IGHG1, and THBS1—distinguished newly diagnosed prostate cancer patients from healthy controls with an AUC of 0.91.
kind
quantitative
target object · 4 fields
value
0.91
unit
auc
tolerance
null
source
We further validated the identified biomarkers against a second cohort, identifying a panel of five key markers (GP5, SERPINA5, ECM1, IGHG1, and THBS1) which retained most of the diagnostic power of the overall dataset, achieving an AUC of 0.91.
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:36831393
locator
sections[0] "Abstract" paragraph 2
quote
We further validated the identified biomarkers against a second cohort, identifying a panel of five key markers (GP5, SERPINA5, ECM1, IGHG1, and THBS1) which retained most of the diagnostic power of the overall dataset, achieving an AUC of 0.91.
state
complete
gaps array · 0 items
experiment object · 8 fields
state
partial
objective
A five-marker serum protein signature—GP5, SERPINA5, ECM1, IGHG1, and THBS1—distinguished newly diagnosed prostate cancer patients from healthy controls with an AUC of 0.91.
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:36831393
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
complete
blocked_on
null
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:PXD025484
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
blocked
blocked_on
method:machine_learning_random_forest
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:PXD025484
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 1 item
[0]
step:run_analysis blocked on method:machine_learning_random_forest
data object · 3 fields
state
partial
assets array · 2 items
[0] object · 15 fields
id
source:pmid:36831393
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.3390/cancers15041051
sha256
sha256:061414ce0daf8c32708730e74e6e8b3c3b9c6d4fcd62f59727053622217a11e3
bytes
67735
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.3390/cancers15041051
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC9954127
source
europe_pmc_fulltext
coverage
whole_body
text_hash_scope
rendered_section_body
[1] object · 15 fields
id
data:geo:PXD025484
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=PXD025484
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
PXD025484
version
null
note
All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary information. Raw data files are available via ProteomeXchange with identifier PXD025484 and can be accessed through ProteomeXchange using reviewer account details: Username: reviewer_pxd025484@ebi.ac.uk and Password: W0lWREBN.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary information. Raw data files are available via ProteomeXchange with identifier PXD025484 and can be accessed through ProteomeXchange using reviewer account details: Username: reviewer_pxd025484@ebi.ac.uk and Password: W0lWREBN.
access_statement_kind
data_availability_statement
sample_accessions array · 0 items
sample_count
null
group_sizes
null
group_sizes_basis
null
platform
null
taxon
null
title
Peripheral blood proteomic signature of newly diagnosed prostate cancer
resolution_checked_at
2026-11-01T18:46:41Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
gaps array · 2 items
[0]
asset:data:geo:PXD025484 not downloaded
[1]
asset:data:geo:PXD025484 licence not read
analysis object · 4 fields
state
partial
methods array · 5 items
[0] object · 10 fields
id
method-1
family
machine_learning
specific
random_forest
label
Machine learning
dsl_operations array · 0 items
missing_operations array · 1 item
[0]
machine_learning_random_forest
expressible
false
parameters object · 0 fields
data_shapes array · 1 item
[0]
labelled_feature_matrix
evidence object · 3 fields
score
1
band
verbatim
quote
A random forest (RF) model was used for feature selection from the initial protein dataset, splitting the data in the ratio of 67:33 (training/testing using stratification), setting ntree to 1000, maximum leaf nodes to 16, and random seed to 1. Recursive feature elimination with cross-validation was used to select the individual features from the training set (maximising accuracy). Classifier model construction was performed using logistic regression.
[1] object · 10 fields
id
method-2
family
group_comparison
specific
wilcoxon
label
Group comparison
dsl_operations array · 0 items
missing_operations array · 1 item
[0]
group_comparison_wilcoxon
expressible
false
parameters object · 0 fields
data_shapes array · 1 item
[0]
two_or_more_groups_continuous
evidence object · 3 fields
score
0.8
band
high
quote
Wilcoxon
[2] object · 10 fields
id
method-3
family
principal_component_analysis
specific
pca
label
Principal component analysis
dsl_operations array · 1 item
[0]
pca_fit
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
wide_numeric_matrix
evidence object · 3 fields
score
0.8
band
high
quote
Principal component analysis
[3] object · 10 fields
id
method-4
family
regression_modelling
specific
ols
label
Regression modelling
dsl_operations array · 1 item
[0]
ols_fit
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
predictors_and_outcome
evidence object · 3 fields
score
0.8
band
high
quote
linear regression
[4] object · 10 fields
id
method-5
family
regression_modelling
specific
logistic
label
Regression modelling
dsl_operations array · 1 item
[0]
glm_logit_fit
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
predictors_and_outcome
evidence object · 3 fields
score
0.8
band
high
quote
logistic regression
targets array · 1 item
[0] object · 8 fields
id
target-published-estimate
claim_id
claim-target-result
operation
glm_logit_fit
unit
auc
tolerance
null
state
complete
note
The published estimate as the reader quoted it from the paper. No tolerance is published because the paper states none.
gaps array · 2 items
[0]
method.reader_differs_from_extractor
[1]
method.machine_learning_random_forest
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
complete
tier
R1
blocked_on
nothing:replicable_now
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
false
required_operations array · 0 items
missing_operations array · 1 item
[0]
machine_learning_random_forest
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: random_forest.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R1
reachable
true
accessions array · 1 item
[0]
PXD025484
resolved_accessions array · 1 item
[0]
PXD025484
statements array · 1 item
[0]
All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary information. Raw data files are available via ProteomeXchange with identifier PXD025484 and can be accessed through ProteomeXchange using reviewer account details: Username: reviewer_pxd025484@ebi.ac.uk and Password: W0lWREBN.
basis
The paper names PXD025484 in ProteomeXchange and the accession resolves in the repository. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 0 items
assets array · 2 items
[0]
source:pmid:36831393
[1]
data:geo:PXD025484
steps array · 0 items
must_build object · 5 fields
dsl_operations array · 1 item
[0] object · 3 fields
operation
machine_learning_random_forest
priority
null
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:PXD025484
gaps array · 0 items
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-11-01T18:31:24Z
independence
single_reader
evidence_check object · 2 fields
method
verbatim
availability
verbatim
calls
5
usage object · 3 fields
prompt_tokens
19391
completion_tokens
1534
cached_tokens
256
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:36831393
type
paper
label
pmid:36831393
[1] object · 3 fields
id
source:pmid:36831393
type
manuscript
label
PMID 36831393 full text
[2] object · 3 fields
id
data:geo:PXD025484
type
dataset
label
GEO PXD025484
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:36831393
type
paper
label
pmid:36831393
[1] object · 3 fields
id
source:pmid:36831393
type
manuscript
label
PMID 36831393 full text
[2] object · 3 fields
id
data:geo:PXD025484
type
dataset
label
GEO PXD025484
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-36831393
type
extraction
used array · 1 item
[0]
source:pmid:36831393
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-PXD025484
type
accession_resolution
used array · 1 item
[0]
data:geo:PXD025484
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:36831393
parent_hash
sha256:988973bc47eb1164b344196da968d0537866e76ff9b7438a150904337518729b
fork_of
null
gaps array · 9 items
[0]
asset:data:geo:PXD025484 licence not read
[1]
asset:data:geo:PXD025484 not downloaded
[2]
execution.not_run
[3]
method.machine_learning_random_forest
[4]
method.reader_differs_from_extractor
[5]
review.human_critique
[6]
review.independent_reader
[7]
review.machine_critique
[8]
step:run_analysis blocked on method:machine_learning_random_forest
assays array · 3 items
[0] object · 11 fields
role
data_generation
definition_id
mass_spectrometry
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 4 items
[0]
A Novel Blood Proteomic Signature for Prostate Cancer.
[1]
0.91. Taken together, this study provides a proteomic signature complementary to PSA for the diagn
[2]
ancer Patients To identify a specific, novel proteomic signature for clinical onset in PCa patients
[3]
ression analysis of the relationship between proteomic signature and PSA score, however, did not fi
order_basis
paper_text_order:0
id
assay:1
[1] object · 11 fields
role
data_generation
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.93
evidence array · 1 item
[0]
addition of PSA level values (as measured by ELISA) further increased the predictive ability of
order_basis
paper_text_order:6837
id
assay:2
[2] object · 11 fields
role
analysis
definition_id
machine_learning
definition_version
f2132e96ae6c7a4e
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
A random forest (RF) model was used for feature selection from the initial protein dataset, splitting the data in the ratio of 67:33 (training/testing using stratification), setting ntree to 1000, maximum leaf nodes to 16, and random seed to 1. Recursive feature elimination with cross-validation was used to select the individual features from the training set (maximising accuracy). Classifier model construction was performed using logistic regression.
order_basis
consumes_earlier_output
id
assay:3
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:36831393", "kind": "science-record", "revision": 4, "content_hash": "sha256:3c91e24ed2c7c79a658ea86f15d528cce702f6da4ef64371694b00bf75034994", "created_at": "2026-11-01T19:01:26Z", "updated_at": "2026-11-01T22:51:21Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "A Novel Blood Proteomic Signature for Prostate Cancer.", "doi": "10.3390/cancers15041051", "pmid": "36831393", "authors": ["Ammara Muazzam", "Matt Spick", "Olivier N F Cexus", "Bethany Geary", "Fowz Azhar", "Hardev Pandha", "Agnieszka Michael", "Rachel Reed", "Sarah Lennon", "Lee A Gethings", "Robert S Plumb", "Anthony D Whetton", "Nophar Geifman", "Paul A Townsend"], "journal": "Cancers", "year": 2023, "abstract": "Prostate cancer is the most common malignant tumour in men. Improved testing for diagnosis, risk prediction, and response to treatment would improve care. Here, we identified a proteomic signature of prostate cancer in peripheral blood using data-independent acquisition mass spectrometry combined with machine learning. A highly predictive signature was derived, which was associated with relevant pathways, including the coagulation, complement, and clotting cascades, as well as plasma lipoprotein particle remodeling. We further validated the identified biomarkers against a second cohort, identifying a panel of five key markers (GP5, SERPINA5, ECM1, IGHG1, and THBS1) which retained most of the diagnostic power of the overall dataset, achieving an AUC of 0.91. Taken together, this study provides a proteomic signature complementary to PSA for the diagnosis of patients with localised prostate cancer, with the further potential for assessing risk of future development of prostate cancer. Data are available via ProteomeXchange with identifier PXD025484.", "claims": [{"id": "claim-method", "statement": "A random forest (RF) model was used for feature selection from the initial protein dataset, splitting the data in the ratio of 67:33 (training/testing using stratification), setting ntree to 1000, maximum leaf nodes to 16, and random seed to 1. Recursive feature elimination with cross-validation was used to select the individual features from the training set (maximising accuracy). Classifier model construction was performed using logistic regression.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:36831393", "locator": "sections[9] \"2.7. Biomarker Analysis and Development and Evaluation of Classification and Regression Models\" paragraph 2", "quote": "A random forest (RF) model was used for feature selection from the initial protein dataset, splitting the data in the ratio of 67:33 (training/testing using stratification), setting ntree to 1000, maximum leaf nodes to 16, and random seed to 1. Recursive feature elimination with cross-validation was used to select the individual features from the training set (maximising accuracy). Classifier model construction was performed using logistic regression."}], "state": "complete"}, {"id": "claim-data-access", "statement": "All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary information. Raw data files are available via ProteomeXchange with identifier PXD025484 and can be accessed through ProteomeXchange using reviewer account details: Username: reviewer_pxd025484@ebi.ac.uk and Password: W0lWREBN.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:36831393", "locator": "sections[22] \"Data Availability Statement\" paragraph 2", "quote": "All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary information. Raw data files are available via ProteomeXchange with identifier PXD025484 and can be accessed through ProteomeXchange using reviewer account details: Username: reviewer_pxd025484@ebi.ac.uk and Password: W0lWREBN."}], "state": "complete"}, {"id": "claim-target-result", "statement": "A five-marker serum protein signature—GP5, SERPINA5, ECM1, IGHG1, and THBS1—distinguished newly diagnosed prostate cancer patients from healthy controls with an AUC of 0.91.", "kind": "quantitative", "target": {"value": 0.91, "unit": "auc", "tolerance": null, "source": "We further validated the identified biomarkers against a second cohort, identifying a panel of five key markers (GP5, SERPINA5, ECM1, IGHG1, and THBS1) which retained most of the diagnostic power of the overall dataset, achieving an AUC of 0.91."}, "evidence": [{"asset": "source:pmid:36831393", "locator": "sections[0] \"Abstract\" paragraph 2", "quote": "We further validated the identified biomarkers against a second cohort, identifying a panel of five key markers (GP5, SERPINA5, ECM1, IGHG1, and THBS1) which retained most of the diagnostic power of the overall dataset, achieving an AUC of 0.91."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "partial", "objective": "A five-marker serum protein signature—GP5, SERPINA5, ECM1, IGHG1, and THBS1—distinguished newly diagnosed prostate cancer patients from healthy controls with an AUC of 0.91.", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:36831393"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:PXD025484"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "blocked", "blocked_on": "method:machine_learning_random_forest", "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:PXD025484"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": ["step:run_analysis blocked on method:machine_learning_random_forest"]}, "data": {"state": "partial", "assets": [{"id": "source:pmid:36831393", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.3390/cancers15041051", "sha256": "sha256:061414ce0daf8c32708730e74e6e8b3c3b9c6d4fcd62f59727053622217a11e3", "bytes": 67735, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.3390/cancers15041051", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC9954127", "source": "europe_pmc_fulltext", "coverage": "whole_body", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:PXD025484", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=PXD025484", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "PXD025484", "version": null, "note": "All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary information. Raw data files are available via ProteomeXchange with identifier PXD025484 and can be accessed through ProteomeXchange using reviewer account details: Username: reviewer_pxd025484@ebi.ac.uk and Password: W0lWREBN.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary information. Raw data files are available via ProteomeXchange with identifier PXD025484 and can be accessed through ProteomeXchange using reviewer account details: Username: reviewer_pxd025484@ebi.ac.uk and Password: W0lWREBN.", "access_statement_kind": "data_availability_statement", "sample_accessions": [], "sample_count": null, "group_sizes": null, "group_sizes_basis": null, "platform": null, "taxon": null, "title": "Peripheral blood proteomic signature of newly diagnosed prostate cancer", "resolution_checked_at": "2026-11-01T18:46:41Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}], "gaps": ["asset:data:geo:PXD025484 not downloaded", "asset:data:geo:PXD025484 licence not read"]}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": "machine_learning", "specific": "random_forest", "label": "Machine learning", "dsl_operations": [], "missing_operations": ["machine_learning_random_forest"], "expressible": false, "parameters": {}, "data_shapes": ["labelled_feature_matrix"], "evidence": {"score": 1.0, "band": "verbatim", "quote": "A random forest (RF) model was used for feature selection from the initial protein dataset, splitting the data in the ratio of 67:33 (training/testing using stratification), setting ntree to 1000, maximum leaf nodes to 16, and random seed to 1. Recursive feature elimination with cross-validation was used to select the individual features from the training set (maximising accuracy). Classifier model construction was performed using logistic regression."}}, {"id": "method-2", "family": "group_comparison", "specific": "wilcoxon", "label": "Group comparison", "dsl_operations": [], "missing_operations": ["group_comparison_wilcoxon"], "expressible": false, "parameters": {}, "data_shapes": ["two_or_more_groups_continuous"], "evidence": {"score": 0.8, "band": "high", "quote": "Wilcoxon"}}, {"id": "method-3", "family": "principal_component_analysis", "specific": "pca", "label": "Principal component analysis", "dsl_operations": ["pca_fit"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["wide_numeric_matrix"], "evidence": {"score": 0.8, "band": "high", "quote": "Principal component analysis"}}, {"id": "method-4", "family": "regression_modelling", "specific": "ols", "label": "Regression modelling", "dsl_operations": ["ols_fit"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["predictors_and_outcome"], "evidence": {"score": 0.8, "band": "high", "quote": "linear regression"}}, {"id": "method-5", "family": "regression_modelling", "specific": "logistic", "label": "Regression modelling", "dsl_operations": ["glm_logit_fit"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["predictors_and_outcome"], "evidence": {"score": 0.8, "band": "high", "quote": "logistic regression"}}], "targets": [{"id": "target-published-estimate", "claim_id": "claim-target-result", "operation": "glm_logit_fit", "expected_value": 0.91, "unit": "auc", "tolerance": null, "state": "complete", "note": "The published estimate as the reader quoted it from the paper. No tolerance is published because the paper states none."}], "gaps": ["method.reader_differs_from_extractor", "method.machine_learning_random_forest"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": false, "required_operations": [], "missing_operations": ["machine_learning_random_forest"], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: random_forest."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["PXD025484"], "resolved_accessions": ["PXD025484"], "statements": ["All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary information. Raw data files are available via ProteomeXchange with identifier PXD025484 and can be accessed through ProteomeXchange using reviewer account details: Username: reviewer_pxd025484@ebi.ac.uk and Password: W0lWREBN."], "basis": "The paper names PXD025484 in ProteomeXchange and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": [], "assets": ["source:pmid:36831393", "data:geo:PXD025484"], "steps": []}, "must_build": {"dsl_operations": [{"operation": "machine_learning_random_forest", "unlocks_papers": null, "priority": null}], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:PXD025484"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-11-01T18:31:24Z", "independence": "single_reader"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 5, "usage": {"prompt_tokens": 19391, "completion_tokens": 1534, "cached_tokens": 256}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:36831393", "type": "paper", "label": "pmid:36831393"}, {"id": "source:pmid:36831393", "type": "manuscript", "label": "PMID 36831393 full text"}, {"id": "data:geo:PXD025484", "type": "dataset", "label": "GEO PXD025484"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:36831393", "type": "paper", "label": "pmid:36831393"}, {"id": "source:pmid:36831393", "type": "manuscript", "label": "PMID 36831393 full text"}, {"id": "data:geo:PXD025484", "type": "dataset", "label": "GEO PXD025484"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-36831393", "type": "extraction", "used": ["source:pmid:36831393"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-PXD025484", "type": "accession_resolution", "used": ["data:geo:PXD025484"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:36831393", "parent_hash": "sha256:988973bc47eb1164b344196da968d0537866e76ff9b7438a150904337518729b", "fork_of": null, "generation": 3}, "gaps": ["asset:data:geo:PXD025484 licence not read", "asset:data:geo:PXD025484 not downloaded", "execution.not_run", "method.machine_learning_random_forest", "method.reader_differs_from_extractor", "review.human_critique", "review.independent_reader", "review.machine_critique", "step:run_analysis blocked on method:machine_learning_random_forest"], "assays": [{"role": "data_generation", "definition_id": "mass_spectrometry", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["A Novel Blood Proteomic Signature for Prostate Cancer.", "0.91. Taken together, this study provides a proteomic signature complementary to PSA for the diagn", "ancer Patients To identify a specific, novel proteomic signature for clinical onset in PCa patients", "ression analysis of the relationship between proteomic signature and PSA score, however, did not fi"], "order_basis": "paper_text_order:0", "id": "assay:1"}, {"role": "data_generation", "definition_id": "elisa", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.93, "evidence": ["addition of PSA level values (as measured by ELISA) further increased the predictive ability of"], "order_basis": "paper_text_order:6837", "id": "assay:2"}, {"role": "analysis", "definition_id": "machine_learning", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 1.0, "evidence": ["A random forest (RF) model was used for feature selection from the initial protein dataset, splitting the data in the ratio of 67:33 (training/testing using stratification), setting ntree to 1000, maximum leaf nodes to 16, and random seed to 1. Recursive feature elimination with cross-validation was used to select the individual features from the training set (maximising accuracy). Classifier model construction was performed using logistic regression."], "order_basis": "consumes_earlier_output", "id": "assay:3"}]}